The Salmeterol Multicenter Asthma Research Trial [1]

Chest

Volumn 130, Issue 3, 2006, Pages 928-

  Sears, Malcolm R ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SALMETEROL;

AFRICAN AMERICAN; AGE; ASTHMA; CLINICAL TRIAL; DRUG RESEARCH; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM; UNITED STATES;

EID: 33748864762     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.3.928     Document Type: Letter

References (5)

1. Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129:15-26
2. Castle W, Fuller R, Hall J, et al. Serevent Nationwide Surveillance Study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993; 306:1034-1037
3. Fuller RW, Castle WM, Hall JR, et al. Bronchodilator treatment in asthma [letter]. BMJ 1993; 306:1611
4. Sears MR, Taylor DR. Bronchodilator treatment in asthma [letter]. BMJ 1993; 307:446
5. McCoy L, Reddelings M, Sorvillo F, et al. A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001. J Asthma 2005; 42:757-763